Nature Communications (Jan 2022)

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

  • Brady T. Hickerson,
  • Tracy R. Daniels-Wells,
  • Cristian Payes,
  • Lars E. Clark,
  • Pierre V. Candelaria,
  • Kevin W. Bailey,
  • Eric J. Sefing,
  • Samantha Zink,
  • James Ziegenbein,
  • Jonathan Abraham,
  • Gustavo Helguera,
  • Manuel L. Penichet,
  • Brian B. Gowen

DOI
https://doi.org/10.1038/s41467-021-27949-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 14

Abstract

Read online

Five New World mammarenaviruses (NWMs) enter cells via binding to human transferrin receptor 1 (hTfR1). Here, Hickerson et al. show that hTfR1 targeting antibodies partially protect hTfR1-transgenic mice from lethal NWM challenge via competition of anti-hTfR1 antibody and viral glycoprotein for hTfR1.